Franklin Wireless Begins Shipping its first 5G Fixed Wireless Router Built for Resilient Connectivity Across Communities and Networks
Globenewswire· 2025-11-03 22:30
SAN DIEGO, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Franklin Wireless Corp (FKWL) announced the JEXtream CG890, a next-generation 5G Fixed Wireless Access (FWA) router designed to deliver reliable, high-speed connectivity for service providers and community-focused organizations. The CG890 bridges the gap between enterprise-grade capability and accessible deployment. Built for versatility, the CG890 is ideal for cost-conscious consumers, small businesses, and nonprofits expanding digital equity programs, as well a ...
Merit Medical Releases 24-Month Efficacy Results from the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial
Globenewswire· 2025-11-03 22:25
At 24 months, the target lesion primary patency (TLPP)1 was 41.7%At 24 months, the access circuit primary patency (ACPP)2 was 25.7% SOUTH JORDAN, Utah, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced 24-month efficacy findings from the non-randomized AVG cohort of the WAVE trial. Results of the AVG cohort were presented during the Late-Breaking Clinical Trials session at the annual VIVA Foundation3 Venous Endovascular In ...
The new shares subscribed for in Aspocomp Group Plc’s Directed Share Issue have been registered with the Trade Register
Globenewswire· 2025-11-03 22:20
Aspocomp Group Plc, Stock Exchange Release, November 3, 2025 at 4:20 p.m.The new shares subscribed for in Aspocomp Group Plc’s directed share issue have been registered with the Trade Register.A total of 673,682 new shares subscribed for in Aspocomp’s Directed Share Issue have been registered with the Finnish Trade Register on October 31, 2025. After the registration of the new shares, the total number of shares in the company is 7,522,922 shares. The new shares will confer equal rights to the company’s exi ...
Alexander’s Announces Third Quarter Financial Results
Globenewswire· 2025-11-03 22:17
PARAMUS, N.J., Nov. 03, 2025 (GLOBE NEWSWIRE) -- ALEXANDER’S, INC. (New York Stock Exchange: ALX) filed its Form 10-Q for the quarter ended September 30, 2025 today and reported: Third Quarter 2025 Financial Results Net income for the quarter ended September 30, 2025 was $6.0 million, or $1.16 per diluted share, compared to $6.7 million, or $1.30 per diluted share for the quarter ended September 30, 2024. Funds from operations (“FFO”) (non-GAAP) for the quarter ended September 30, 2025 was $14.9 million, or ...
Diana Shipping Inc. Announces Time Charter Contract for m/v Los Angeles with MOL and Direct Continuation of Time Charter Contract for m/v DSI Aquarius with Bunge
Globenewswire· 2025-11-03 22:15
ATHENS, Greece, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Diana Shipping Inc. (NYSE: DSX), (the “Company”), a global shipping company specializing in the ownership and bareboat charter-in of dry bulk vessels, today announced that, through a separate wholly-owned subsidiary, it has entered into a time charter contract with MOL Ocean Bulk Pte. Ltd., Singapore, for one of its Newcastlemax dry bulk vessels, the m/v Los Angeles. The gross charter rate is US$24,000, minus a 5.00% commission paid to third parties, for a p ...
Cellectis to Present a Development Update for eti-cel at ASH 2025
Globenewswire· 2025-11-03 22:15
Preliminary data recently shared for eti-cel (UCART20x22) show an 86% ORR and a 57% CR rate (n=7), underscoring its potential to improve outcomes in r/r NHLPreclinical data demonstrated that combining eti-cel with low-dose IL-2 may deepen and extend anti-tumor activity in patients with r/r NHLEti-cel full Phase 1 dataset, including low-dose IL-2 combination cohorts, expected to be presented in 2026Correlation between alemtuzumab exposure and response with lasme-cel (UCART22) allows optimization of efficacy ...
Capricor Therapeutics Publishes Peer-Reviewed Study in Biomedicines Describing the Mechanism of Action and Potency Assay for its Investigational Cell Therapy, Deramiocel
Globenewswire· 2025-11-03 22:15
–Publication highlights Deramiocel’s anti-fibrotic activity and describes a validated potency assay supporting quality control and product consistency in late-stage development– SAN DIEGO, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics, Inc. (NASDAQ: CAPR), a biotechnology company developing cell and exosome-based therapies for rare diseases, today announced the publication in Biomedicines, an international peer-reviewed journal, describing a novel in-vitro potency assay designed to characterize t ...
Beyond Meat® Introduces New Value Pack of Its Latest Beyond Beef® at Retailers Across Canada
Globenewswire· 2025-11-03 22:15
The new 2-pack will be rolling into over 1,300 stores across the country Beyond Beef Italian Zoodles Beyond Beef delivers a juicy, meaty flavour and, due to avocado oil’s high smoke point, it sizzles and caramelizes to perfection. Beyond Beef 2-Pack The new Beyond Beef 2-Pack offers more than 2.5 times the amount of Beyond Beef versus the current single pack and is made with clean, simple ingredients like protein from red lentils and faba beans. EL SEGUNDO, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- B ...
MIMEDX Comments on CY 2026 Medicare Physician Fee Schedule Final Rule
Globenewswire· 2025-11-03 22:15
Company is Well Positioned to Continue to Compete and GrowMARIETTA, Ga., Nov. 03, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today commented on the Centers for Medicare and Medicaid Services (“CMS”) release of the CY 2026 Physician Fee Schedule (“PFS”) final rule, which was published on Friday. “Over the last several years, we have actively engaged with numerous stakeholders to advocate for much-needed reform of the Medicare reimbursement system for skin substitut ...
UTime Limited Explores Application of AI Technology in Health Data Analysis
Globenewswire· 2025-11-03 22:15
UTime Limited UTime Limited Explores Application of AI Technology in Health Data Analysis UTime Limited The company is developing AI-based algorithm models SHENZHEN, China, Nov. 03, 2025 (GLOBE NEWSWIRE) -- UTime Limited (Nasdaq: WTO) today outlined its ongoing exploration in the field of health data analysis, particularly the potential application of artificial intelligence (AI) technologies. UTime is developing AI-based algorithm models aimed at performing in-depth analysis of continuous physiol ...